Drug intelligence / Profile preview

filociclovir

Development stage
Phase 1
Lead developer
Microbiotix
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral (capsule)
01

Overview

Filociclovir is a second-generation methylene cyclopropane compound and a purine nucleoside analogue with broad-spectrum antiviral activity. It acts primarily as a DNA-directed DNA polymerase inhibitor and ganciclovir kinase inhibitor. Filociclovir is structurally related to guanosine and functions by inhibiting viral replication through interference with viral DNA polymerases. It has demonstrated potent in vitro activity against human cytomegalovirus (HCMV), being approximately ten times more effective than ganciclovir without increased cytotoxicity. The drug is under development for the treatment of cytomegalovirus infections and has also shown activity against other herpesviruses such as HHV-6 and HHV-8[1][3][4][9].

Other names
filociclovircyclopropavir
02

Targets

UL97 (HCMV UL97 kinase)CMV DNA polymerase (Human cytomegalovirus DNA polymerase)

Beyond the preview

Go deeper on filociclovir.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on filociclovir.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call